Characterization of Immune Cells in the Eyes of Patients with Diabetes Mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012304

Enrollment

500

Registered

2017-04-24

Start date

2017-05-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy H36.0

Interventions

Group 1: Samples (conjunctiva resectates, anterior chamber puncture fluids, fibrovascular membranes and vitreous body aspirates) from patients, suffering from diabetic retinopathy, and with a conseque

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients, suffering from diabetic retinopathy (n=250) and non-diabetic patients with an indication for a retinal surgery, other than diabetic retinopathy (macular hole, epiretinal gliosis, rhegmatogenous retinal detachment, choroidal tumors) (n=250)

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The aim of this study consists in the analysis of the histological, immunhistochemical, flow cytometric and molecular genetic profile of the immune cells in the eyes of patients suffering from diabetic retinopathy.	—

Countries

Germany

Contacts

Public ContactStefaniya Boneva

Klinik für Augenheilkunde, Universitätsklinikum Freiburg

stefaniya.boneva@uniklinik-freiburg.de0761 27040512

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026